Product Images Duloxetine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Duloxetine NDC 71205-525 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

71205-525-30 - image 01

71205-525-30 - image 01

This is the description of Duloxetine 20mg capsules with NDC 71205-525-30 by ProficientRx. Each delayed-release capsule contains 22.4mg of duloxetine hydrochloride, USP equivalent to 20mg duloxetine. The capsules are blue opaque cap and body, imprinted with "logo" and 2890 on both cap and body in black ink. These capsules are RX only and should be dispensed with the medication guide provided separately to each patient. The product is manufactured by Actavis Eizabeth LLC Eizabeth, NJ 07207 USA and packaged by Proficient Rx LP, Thousand Oaks, CA 91320. The GTIN is 0037120525309 and the expiry date is 00/0000 with Lot#00000.*

1 - image 1

1 - image 1

figure6 - image 10

figure6 - image 10

figure8 - image 11

figure8 - image 11

This text displays a chart comparing the percentage of patients improved with either a placebo or duloxetine delayed-release 60/120 mg once daily. The chart also includes the percent improvement in pain from baseline.*

figure9 - image 12

figure9 - image 12

The text provides a graph representing the percentage of patients who reported improvements with Duloxetine Delayed-Release 60 mg once daily and a placebo. There is also a line chart representing the percent improvement in pain from the baseline. Therefore, the description would be: "The text shows a graph comparing the effectiveness of Duloxetine Delayed-Release 60 mg once daily and a placebo, and a line chart displaying the percentage of improvement in pain from baseline."*

figure10 - image 13

figure10 - image 13

The text provides data on the percentage of patients improved with placebo and Duloxetine Delayed-Release 60/120 mg Once Daily. It also gives information on the percent improvement in pain from the baseline.*

1 - image 14

1 - image 14

1 - image 2

1 - image 2

1 - image 3

1 - image 3

1 - image 4

1 - image 4

figure1 - image 5

figure1 - image 5

figure2 - image 6

figure2 - image 6

The text describes a graph showing the proportion of patients with relapse over time from randomization to relapse in days on a clinical trial of placebo versus duloxetine delayed-release capsules. The graph appears to use a Kaplan-Meier method for analysis.*

figure3 - image 7

figure3 - image 7

This text provides a heading titled "Percentage of Patients Improved" followed by a blank space and then another heading "Percent Improvement in Pain from Baseline". It does not contain any further information or context to determine what it refers to.*

figure4 - image 8

figure4 - image 8

figure5 - image 9

figure5 - image 9

The text shows a chart that displays the percentage of improvement in pain from baseline for three different medications - DUL 60 mg Twice Daily, DUL 60 mg Once Daily, and Placebo.*

image2890

image2890

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.